Retatrutide is hypothesized to act as a triple receptor agonist in preclinical models, interacting with pathways commonly associated with glucagon, GLP-1 (glucagon-like peptide-1), and GIP (glucose-dependent insulinotropic polypeptide)
Semaglutide has consistently demonstrated better reductions in HbA1c and body weight compared to placebo and a variety of active comparators, including sitagliptin, exenatide extended release, insulin glargine, dulaglutide, canagliflozin, and liraglutide
Energy levels may fluctuate as your body adapts to reduced caloric intake
Box 2 Protein kinase C (PKC), as a family of protein kinase enzymes, plays a vital part in several signal transduction cascades and have the ability to regulate other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues
When thyroid hormone replacement is optimized, meaning your TSH is within target range and you feel well, your metabolic rate returns to approximately normal
Its likely the drug will increase accessibility, remove barriers and lead to a rising number of patients using GLP-1s to lose and manage their weight